Company Description
Amgen is among the biggest of the biotech big'uns. And it's determined to get even bigger. The company uses cellular biology and medicinal chemistry...
Key Amgen Financials
| Company Type | Public - NASDAQ (GS): AMGN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $14,771.0 |
| 2007 Employees | 17,500 |
More Amgen Financials (11 pages)
Latest Amgen Jobs jobs by Indeed
Rankings
- #173 in FORTUNE 500
- S&P 500
- #115 in FT Global 500
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Amgen's competition across multiple industries
Top Amgen Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Amgen Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, and CEO | Kevin W. Sharer | Network | E-mail |
| EVP Operations | Dennis M. Fenton | Network | E-mail |
| EVP Global Commercial Operations | George J. Morrow | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Amgen News
- [DIAG]-Product Briefs [AHC Newsletters] (03 Jul 2008 00:01:00 EDT)
- BioWorld Today July 3, 2008 [BioWorld Today] (03 Jul 2008 00:01:00 EDT)
- Substituted quinolinone derivatives and methods of use [U.S. Patents] (01 Jul 2008 13:22:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.